# Fitlife Brands, Inc.: financial statements, quarterly

FTLF · Nasdaq · CIK 1374328 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ftlf.md) · [Financials](/companies/ftlf/financials.md) · [Filings](/companies/ftlf/filings.md) · [Insiders](/companies/ftlf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ftlf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [13.9](/filings/0001437749-24-035027.md) | [13.3 d](/filings/0001437749-25-009469.md) | [16.5](/filings/0001437749-25-016990.md) | [16.9](/filings/0001437749-25-026661.md) | [16.0](/filings/0001437749-25-034607.md) | [15.0 d](/filings/0001437749-26-010680.md) | [15.9](/filings/0001437749-26-016875.md) | [16.1](/filings/0001437749-26-027478.md) | [23.5](/filings/0001437749-25-034607.md) | [(39.6) d](/filings/0001437749-26-016875.md) | [25.3](/filings/0001437749-26-016875.md) | [26.5](/filings/0001437749-26-027478.md) |
| Cost of revenue | $m | [8.2](/filings/0001437749-24-035027.md) | [7.9 d](/filings/0001437749-25-009469.md) | [9.3](/filings/0001437749-25-016990.md) | [9.4](/filings/0001437749-25-026661.md) | [9.0](/filings/0001437749-25-034607.md) | [8.8 d](/filings/0001437749-26-010680.md) | [9.1](/filings/0001437749-25-016990.md) | [9.2](/filings/0001437749-26-027478.md) | [14.7](/filings/0001437749-25-034607.md) | [(24.0) d](/filings/0001437749-26-016875.md) | [15.8](/filings/0001437749-26-016875.md) | [16.7](/filings/0001437749-26-027478.md) |
| Gross profit | $m | [5.7](/filings/0001437749-24-035027.md) | [5.4 d](/filings/0001437749-25-009469.md) | [7.3](/filings/0001437749-25-016990.md) | [7.6](/filings/0001437749-25-026661.md) | [7.0](/filings/0001437749-25-034607.md) | [6.2 d](/filings/0001437749-26-010680.md) | [6.9](/filings/0001437749-25-016990.md) | [6.9](/filings/0001437749-26-027478.md) | [8.7](/filings/0001437749-25-034607.md) | [(15.6) d](/filings/0001437749-26-016875.md) | [9.5](/filings/0001437749-26-016875.md) | [9.8](/filings/0001437749-26-027478.md) |
| Selling, general and administrative | $m | [1.9](/filings/0001437749-24-035027.md) | [2.5 d](/filings/0001437749-25-009469.md) | [2.5](/filings/0001437749-25-016990.md) | [2.5](/filings/0001437749-25-026661.md) | [2.6](/filings/0001437749-25-034607.md) | [2.3 d](/filings/0001437749-26-010680.md) | [2.5](/filings/0001437749-25-016990.md) | [2.5](/filings/0001437749-26-027478.md) | [4.1](/filings/0001437749-25-034607.md) | [(6.6) d](/filings/0001437749-26-016875.md) | [5.0](/filings/0001437749-26-016875.md) | [4.8](/filings/0001437749-26-027478.md) |
| Operating income | $m | [2.5](/filings/0001437749-24-035027.md) | [1.8 d](/filings/0001437749-25-009469.md) | [3.4](/filings/0001437749-25-016990.md) | [3.7](/filings/0001437749-25-026661.md) | [3.2](/filings/0001437749-25-034607.md) | [2.9 d](/filings/0001437749-26-010680.md) | [3.0](/filings/0001437749-25-016990.md) | [2.5](/filings/0001437749-26-027478.md) | [2.3](/filings/0001437749-25-034607.md) | [(4.8) d](/filings/0001437749-26-016875.md) | [3.1](/filings/0001437749-26-016875.md) | [3.4](/filings/0001437749-26-027478.md) |
| Interest expense | $m | [0.2](/filings/0001437749-23-031385.md) | [0.4 d](/filings/0001437749-24-010119.md) | [0.4](/filings/0001437749-24-016353.md) | [0.3](/filings/0001437749-25-026661.md) | [0.3](/filings/0001437749-25-034607.md) | [0.3 d](/filings/0001437749-26-010680.md) | [0.2](/filings/0001437749-25-016990.md) | [0.2](/filings/0001437749-26-027478.md) | [0.6](/filings/0001437749-25-034607.md) | [(0.8) d](/filings/0001437749-26-016875.md) | [0.7](/filings/0001437749-26-016875.md) | [0.7](/filings/0001437749-26-027478.md) |
| Income tax | $m | [0.4](/filings/0001437749-24-035027.md) | [0.2 d](/filings/0001437749-25-009469.md) | [0.8](/filings/0001437749-25-016990.md) | [0.7](/filings/0001437749-25-026661.md) | [0.8](/filings/0001437749-25-034607.md) | [0.6 d](/filings/0001437749-26-010680.md) | [0.7](/filings/0001437749-25-016990.md) | [0.6](/filings/0001437749-26-027478.md) | [0.8](/filings/0001437749-25-034607.md) | [(1.5) d](/filings/0001437749-26-016875.md) | [0.6](/filings/0001437749-26-016875.md) | [0.7](/filings/0001437749-26-027478.md) |
| Net income | $m | [1.7](/filings/0001437749-24-035027.md) | [1.5 d](/filings/0001437749-25-009469.md) | [2.2](/filings/0001437749-25-016990.md) | [2.6](/filings/0001437749-25-026661.md) | [2.1](/filings/0001437749-25-034607.md) | [2.1 d](/filings/0001437749-26-010680.md) | [2.0](/filings/0001437749-26-016875.md) | [1.7](/filings/0001437749-26-027478.md) | [0.9](/filings/0001437749-25-034607.md) | [(2.7) d](/filings/0001437749-26-016875.md) | [1.7](/filings/0001437749-26-016875.md) | [2.0](/filings/0001437749-26-027478.md) |
| Diluted EPS | $ per share | [0.35](/filings/0001437749-24-035027.md) | not reported | [0.21](/filings/0001437749-25-016990.md) | [0.27](/filings/0001437749-25-026661.md) | [0.21](/filings/0001437749-25-034607.md) | not reported | [0.20](/filings/0001437749-25-016990.md) | [0.18](/filings/0001437749-26-027478.md) | [0.09](/filings/0001437749-25-034607.md) | not reported | [0.17](/filings/0001437749-26-016875.md) | [0.20](/filings/0001437749-26-027478.md) |
| Basic EPS | $ per share | [0.38](/filings/0001437749-24-035027.md) | not reported | [0.23](/filings/0001437749-25-016990.md) | [0.29](/filings/0001437749-25-026661.md) | [0.23](/filings/0001437749-25-034607.md) | not reported | [0.22](/filings/0001437749-25-016990.md) | [0.19](/filings/0001437749-26-027478.md) | [0.10](/filings/0001437749-25-034607.md) | not reported | [0.18](/filings/0001437749-26-016875.md) | [0.21](/filings/0001437749-26-027478.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.3](/filings/0001437749-23-031385.md) | [1.1](/filings/0001437749-25-009469.md) | [2.5](/filings/0001437749-24-016353.md) | [3.7](/filings/0001437749-24-026562.md) | [4.7](/filings/0001437749-24-035027.md) | [4.5](/filings/0001437749-26-010680.md) | [5.9](/filings/0001437749-25-016990.md) | [1.5](/filings/0001437749-25-026661.md) | [3.5](/filings/0001437749-25-034607.md) | [1.6](/filings/0001437749-26-027478.md) | [1.2](/filings/0001437749-26-016875.md) | [1.1](/filings/0001437749-26-027478.md) |
| Current assets | $m | [19.5](/filings/0001437749-23-031385.md) | [14.7](/filings/0001437749-25-009469.md) | [15.0](/filings/0001437749-24-016353.md) | [17.0](/filings/0001437749-24-026562.md) | [18.1](/filings/0001437749-24-035027.md) | [18.1](/filings/0001437749-26-010680.md) | [21.8](/filings/0001437749-25-016990.md) | [22.2](/filings/0001437749-25-026661.md) | [37.4](/filings/0001437749-25-034607.md) | [33.1](/filings/0001437749-26-027478.md) | [31.6](/filings/0001437749-26-016875.md) | [30.6](/filings/0001437749-26-027478.md) |
| Total assets | $m | [44.0](/filings/0001437749-23-031385.md) | [55.3](/filings/0001437749-25-009469.md) | [55.5](/filings/0001437749-24-016353.md) | [57.3](/filings/0001437749-24-026562.md) | [58.6](/filings/0001437749-24-035027.md) | [58.5](/filings/0001437749-26-010680.md) | [62.2](/filings/0001437749-25-016990.md) | [62.8](/filings/0001437749-25-026661.md) | [110](/filings/0001437749-25-034607.md) | [106](/filings/0001437749-26-027478.md) | [104](/filings/0001437749-26-016875.md) | [103](/filings/0001437749-26-027478.md) |
| Current liabilities | $m | [7.4](/filings/0001437749-23-031385.md) | [10.3](/filings/0001437749-25-009469.md) | [11.8](/filings/0001437749-24-016353.md) | [12.3](/filings/0001437749-24-026562.md) | [12.1](/filings/0001437749-24-035027.md) | [11.3](/filings/0001437749-26-010680.md) | [13.3](/filings/0001437749-25-016990.md) | [13.0](/filings/0001437749-25-026661.md) | [33.0](/filings/0001437749-25-034607.md) | [21.6](/filings/0001437749-26-027478.md) | [20.8](/filings/0001437749-26-016875.md) | [20.9](/filings/0001437749-26-027478.md) |
| Total liabilities | $m | [18.7](/filings/0001437749-23-031385.md) | [28.3](/filings/0001437749-25-009469.md) | [26.1](/filings/0001437749-24-016353.md) | [25.5](/filings/0001437749-24-026562.md) | [24.4](/filings/0001437749-24-035027.md) | [22.4](/filings/0001437749-26-010680.md) | [23.3](/filings/0001437749-25-016990.md) | [21.9](/filings/0001437749-25-026661.md) | [68.1](/filings/0001437749-25-034607.md) | [62.7](/filings/0001437749-26-027478.md) | [58.9](/filings/0001437749-26-016875.md) | [55.2](/filings/0001437749-26-027478.md) |
| Long-term debt | $m | [8.8](/filings/0001437749-23-031385.md) | [15.5](/filings/0001437749-25-009469.md) | [11.9](/filings/0001437749-24-016353.md) | [10.8](/filings/0001437749-24-026562.md) | [9.7](/filings/0001437749-24-035027.md) | [8.6](/filings/0001437749-25-034607.md) | [7.4](/filings/0001437749-25-016990.md) | [6.3](/filings/0001437749-25-026661.md) | [32.4](/filings/0001437749-25-034607.md) | not reported | not reported | not reported |
| Current portion of debt | $m | [2.5](/filings/0001437749-23-031385.md) | not reported | not reported | not reported | not reported | [4.5](/filings/0001437749-25-034607.md) | not reported | not reported | [14.1](/filings/0001437749-25-034607.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [25.2](/filings/0001437749-24-035027.md) | [27.0](/filings/0001437749-26-010680.md) | [29.4](/filings/0001437749-25-026661.md) | [31.9](/filings/0001437749-25-034607.md) | [34.2](/filings/0001437749-25-034607.md) | [36.1](/filings/0001437749-26-027478.md) | [38.9](/filings/0001437749-26-027478.md) | [40.9](/filings/0001437749-26-027478.md) | [41.9](/filings/0001437749-25-034607.md) | [43.6](/filings/0001437749-26-027478.md) | [45.4](/filings/0001437749-26-027478.md) | [47.4](/filings/0001437749-26-027478.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [978 d](/filings/0001437749-24-035027.md) | [1,448 d](/filings/0001437749-25-009469.md) | [5,036](/filings/0001437749-25-016990.md) | [1,570 d](/filings/0001437749-25-026661.md) | [2,047 d](/filings/0001437749-25-034607.md) | [957 d](/filings/0001437749-26-010680.md) | [2,328](/filings/0001437749-26-016875.md) | [1,195 d](/filings/0001437749-26-027478.md) | [3,672 d](/filings/0001437749-25-034607.md) | [244 d](/filings/0001437749-26-010680.md) | [2,484](/filings/0001437749-26-016875.md) | [3,635 d](/filings/0001437749-26-027478.md) |
| Capital expenditure | $k | [6.0 d](/filings/0001437749-24-035027.md) | [46.0 d](/filings/0001437749-25-009469.md) | [10.0](/filings/0001437749-25-016990.md) | [0.0 d](/filings/0001437749-25-026661.md) | [0.0 d](/filings/0001437749-25-034607.md) | [0.0 d](/filings/0001437749-26-010680.md) | [24.0](/filings/0001437749-26-016875.md) | [5.0 d](/filings/0001437749-26-027478.md) | [8.0 d](/filings/0001437749-25-034607.md) | [5.0 d](/filings/0001437749-26-010680.md) | [0.0](/filings/0001437749-26-016875.md) | [0.0 d](/filings/0001437749-26-027478.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.0](/filings/0001437749-23-031385.md) | [4.9](/filings/0001437749-24-016353.md) | [4.9](/filings/0001437749-24-026562.md) | [4.9](/filings/0001437749-24-035027.md) | [10.1](/filings/0001437749-25-016990.md) | [9.9](/filings/0001437749-25-026661.md) | [9.9](/filings/0001437749-25-034607.md) | [9.9](/filings/0001437749-26-016875.md) | [10.0](/filings/0001437749-26-027478.md) | [10.0](/filings/0001437749-25-034607.md) | [10.0](/filings/0001437749-26-016875.md) | [9.9](/filings/0001437749-26-027478.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,391,072 at 2026-08-12, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027478.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.